Scholars

Nabity, Mary

Associate Professor

Positions:

Associate Professor, Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences

Research Areas:

Alport syndrome, Biochemical markers, Biomarkers, Canine glomerular disease, Chronic renal failure

Single Page Bio

mnabity@tamu.edu

1 979 845 9180

Co-author Network

Map of Science

Co-investigator Network

Research Areas:

Alport syndrome, Biochemical markers, Biomarkers, Canine glomerular disease, Chronic renal failure

overview

My research interests involve the pathogenesis of kidney disease and investigation of novel biomarkers in dogs and cats with chronic kidney disease and their relation to conventional measures of renal function. In our lab, we are actively exploring urinary proteins, mRNAs, and miRNAs in dogs with naturally occurring glomerular disease in order to determine their ability to serve as early markers of renal disease, specific markers of certain types of renal disease and disease progression, and targets for novel therapies. Our goal is to improve our understanding of the development and progression of kidney disease and to develop and validate testing methods in order to more effectively diagnosis and monitor renal disease in companion animals and humans.

education and training

Ph.D. in Veterinary Pathology, Texas A&M University - (College Station, Texas, United States) 2010
D.V.M. in Veterinary Medicine, Cornell University - (Ithaca, New York, United States) 2002
B.S. in Biochemistry, University of Nebraska–Lincoln - (Lincoln, United States) 1998

selected publications

Academic Articles51

Chu, C. P., Hokamp, J. A., Cianciolo, R. E., Dabney, A. R., Brinkmeyer-Langford, C., Lees, G. E., & Nabity, M. B. (2020). Author Correction: RNA-seq of serial kidney biopsies obtained during progression of chronic kidney disease from dogs with X-linked hereditary nephropathy. SCIENTIFIC REPORTS. 10(1), 2381.
Grimes, M., Heseltine, J. C., Nabity, M. B., Lawhon, S. D., Wheeler, L., Cigarroa, A., & Lidbury, J. A. (2020). Characteristics associated with bacterial growth in urine in 451 proteinuric dogs (2008‐2018). Journal of Veterinary Internal Medicine. 34(2), 770-776.
Rhode, H., Muckova, P., Büchler, R., Wendler, S., Tautkus, B., Vogel, M., ... Nabity, M. (2019). A next generation setup for pre-fractionation of non-denatured proteins reveals diverse albumin proteoforms each carrying several post-translational modifications. SCIENTIFIC REPORTS. 9(1), 11733.
Zou, D., Ganugula, R., Arora, M., Nabity, M. B., Sheikh-Hamad, D., & Kumar, M. (2019). Oral delivery of nanoparticle urolithin A normalizes cellular stress and improves survival in mouse model of cisplatin-induced AKI. American Journal of Physiology. Renal physiology. 317(5), f1255-f1264.
Chu, C. P., & Nabity, M. B. (2019). Comparison of RNA isolation and library preparation methods for small RNA sequencing of canine biofluids. Veterinary Clinical Pathology. 48(2), 310-319.

Chapters6

Clark, S. D., & Nabity, M. B. (2020). 24 Male Reproductive Tract Prostate, Testes, Penis, and Semen. Cowell and Tyler's Diagnostic Cytology and Hematology of the Dog and Cat. (pp. 406-422). Elsevier.
Nabity, M. B., & Ramaiah, S. K. (2012). Blood and bone marrow toxicity. Veterinary Toxicology. (pp. 351-363). Elsevier.
Nabity, M. B., & Ramaiah, S. K. (2012). Chapter 22 Blood and bone marrow toxicity. Veterinary Toxicology. (pp. 351-363).
Nabity, M. B. (2011). Urine Protein and Microalbuminuria. Nephrology and Urology of Small Animals. (pp. 58-61). John Wiley & Sons, Ltd..
Ramaiah, S. K., & Nabity, M. B. (2007). Blood and bone marrow toxicity. Veterinary Toxicology. (pp. 277-288). Elsevier.